United States - English - NLM (National Library of Medicine)

artesa labs, llc - flurandrenolide (unii: 8eul29xuqt) (flurandrenolide - unii:8eul29xuqt) - flurandrenolide 0.5 mg in 1 ml - nolix ® lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of components of the preparation.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - flurandrenolide (unii: 8eul29xuqt) (flurandrenolide - unii:8eul29xuqt) - nolix ™ cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of components of the preparation.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - urea (unii: 8w8t17847w) (urea - unii:8w8t17847w) - urea 410 mg in 1 g - this product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), iodoquinol (unii: 63w7ie88k8) (iodoquinol - unii:63w7ie88k8) - hydrocortisone acetate 19 mg in 1 g - based on a review of a related drug by the national research council and subsequent fda classification for that drug, the indications are as follows: “possibly” effective: contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); monliasis; intertrigo. final classification of the less-than-effective indications requires further investigation. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - this product is indicated in the treatment of symptoms associated with xerosis (dry, scaly skin). this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide ointment, usp 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cupric oxide (unii: v1xjq704r4) (cupric cation - unii:8cbv67279l), zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - niacin 250 mg - this product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product. this product is contraindicated in patients with known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide gel, 0.05% is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. patients should be instructed to use desonide gel, 0.05% for the minimum amount of time as necessary to achieve the desired results because of the potential for desonide gel, 0.05% to suppress the hypothalamicpituitary-adrenal (hpa) axis [see warnings and precautions ( 5.1)]. treatment should not exceed 4 consecutive weeks [see dosage and administration ( 2)]. desonide gel, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. teratogenic effects: pregnancy category c: there are no adequate and well-controlled studies in pregnant women. therefore, desonide gel, 0.05% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some

United States - English - NLM (National Library of Medicine)

artesa labs, llc - selenium sulfide (unii: z69d9e381q) (selenium sulfide - unii:z69d9e381q) - selenium sulfide 23 mg in 1 ml - this product is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. urea hydrates and is useful for conditions such as dry scalp. this product is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. urea hydrates and is useful for conditions such as dry scalp.

United States - English - NLM (National Library of Medicine)

artesa labs, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne treatment for the treatment of acne do not use if you - have very sensitive skin - are sensitive to benzoyl peroxide stop use and ask a doctor if irritation becomes severe.